Filing Details
- Accession Number:
- 0001181431-12-002876
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-01-18 15:30:13
- Reporting Period:
- 2012-01-13
- Filing Date:
- 2012-01-18
- Accepted Time:
- 2012-01-18 15:30:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
819050 | Vical Inc | VICL | Biological Products, (No Disgnostic Substances) (2836) | 930948554 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1305178 | Marie Jill Broadfoot | 10390 Pacific Center Court San Diego CA 92121 | Sr Vice President, Cfo, Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock $.01 Par Value | Acquisiton | 2012-01-13 | 27,000 | $0.01 | 207,875 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2012-01-13 | 29,875 | $0.00 | 29,875 | $3.67 |
Common Stock | Nonstatutory Stock Option (right to buy) | Acquisiton | 2012-01-13 | 117,125 | $0.00 | 117,125 | $3.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
644,875 | 2013-01-13 | 2022-01-12 | No | 4 | A | Direct |
762,000 | 2013-01-13 | 2022-01-12 | No | 4 | A | Direct |
Footnotes
- Shares were acquired pursuant to a restricted stock grant.
- The right to exercise the above stock options generally vests 25% on the first anniversary date of the grant, with the remaining rights vesting quarterly over the remaining three years.
- This balance includes 120,750 of unvested restricted stock units.